N1 Life
Pioneering drug delivery technology company accelerating science to solve unmet medical needs, focusing on drug discovery and development and featuring AbsotrideTM Peptide-based Delivery Platform and ChARLSTM Polymer-based Delivery Platform.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Apr 2023.)
Milpitas California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $10.0m | Seed | |
Total Funding | €9.1m |